Amit Parulekar
Senior Director - Clinical Development Medical Lead Generate Biomedicines, Inc
Seminars
Thursday 17th September 2026
Roundtable Discussion: Targeted Patient Segmentation Strategies to Unlock Therapeutic Response in a Heterogeneous Condition
11:45 am
- Explore how an endotype‑driven stratification framework that integrates clinical features, molecular biomarkers, and environmental exposure history can improve treatment selection and therapeutic precision in COPD
- Understand how identifying patients most likely to benefit from biologic or targeted interventions, such as those with eosinophilic or other mechanistically defined subtypes, may accelerate successful outcomes and guide personalized approaches
- Appreciate why better patient stratification, beyond traditional spirometric or broad clinical categories, could dramatically reduce trial size and duration while enhancing the predictive validity of clinical endpoints
